Clinical Trials

Transforming the lives of patients everywhere.

Hoth Therapeutics

We are committed to the patient experience by following the science to develop impactful and versatile treatment solutions for everyone. At HOTH, we stand by our mission to innovate today for a better tomorrow.

Learn more about our therapeutic areas and Early Access program opportunities.

If you have questions regarding our clinical trials, please contact us here.

Currently Recruiting


Phase 2a Clinical Trial

Safety, preliminary efficacy and pharmacokinetics of Application of Topical HT-001 in Adult Subjects and Patients In EGFR Inhibitor Therapy.

Clinical Trial Information

Enrollment Closed


Phase 1b Clinical Trial

Safety, Tolerability, Pharmacokinetics and Efficacy of Twice Daily Application of Topical BioLexa in Adult Healthy Subjects and Patients With Mild to Moderate Atopic Dermatitis.

Expanded Access
& Compassionate Use

We understand that there are critically ill patients who will not meet all of the criteria to enroll in our clinical trials and don’t have options for alternative therapies.